| Genzyme Belgium | Genzyme Corporate | Search | Contact us | |||||||||
![]() |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
Pharmacovigilance / Safety Information Genzyme maintains a worldwide database of adverse events that have occurred in patients receiving Aldurazyme® enzyme replacement therapy. Please promptly report all adverse events (infusion-related or otherwise) by completing an Adverse Event Form and fax it to +32 2 714 17 07. You can also call Genzyme Belgium at +32 2 714 17 11 or e-mail us. In case of unexpected adverse events, a search for comparable events can be requested. The report on such a search may be helpful in the evaluation and management of unexpected events. |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Terms and Conditions of Use | Privacy Policy | © 2012 Genzyme Corporation, a Sanofi Company. All rights reserved. | ||